BIOMAT Database Logo BIOMAT Database Logo

Reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine. 1984

I F Casson, and J N Harvey, and M R Lee

UI MeSH Term Description Entries
D002394 Catechol O-Methyltransferase Enzyme that catalyzes the movement of a methyl group from S-adenosylmethionone to a catechol or a catecholamine. Catechol Methyltransferase,Catechol-O-Methyltransferase,Catechol O Methyltransferase,Methyltransferase, Catechol,O-Methyltransferase, Catechol
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D004793 Enzyme Reactivators Compounds which restore enzymatic activity by removing an inhibitory group bound to the reactive site of the enzyme. Reactivators, Enzyme
D000535 Aluminum A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. Aluminium,Aluminium-27,Aluminum-27,Aluminium 27,Aluminum 27

Related Publications

I F Casson, and J N Harvey, and M R Lee
Radioenzymatic assay of catecholamines: reversal of aluminium inhibition of enzymatic O-methylation by desferrioxamine.
March 1983, Annals of clinical biochemistry,
I F Casson, and J N Harvey, and M R Lee
Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.
November 1981, Lancet (London, England),
I F Casson, and J N Harvey, and M R Lee
Partial reversal of aluminium-induced neurofibrillary degeneration by desferrioxamine in adult male rabbits.
February 1994, Neuropathology and applied neurobiology,
I F Casson, and J N Harvey, and M R Lee
Inhibition of heme-promoted enzymatic lipid peroxidation by desferrioxamine and EDTA.
January 1988, Upsala journal of medical sciences,
I F Casson, and J N Harvey, and M R Lee
Desferrioxamine, aluminium, and dialysis.
January 1983, Lancet (London, England),
I F Casson, and J N Harvey, and M R Lee
Successful treatment of aluminium encephalopathy by intraperitoneal desferrioxamine.
May 1984, Lancet (London, England),
I F Casson, and J N Harvey, and M R Lee
Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy.
February 1993, Postgraduate medical journal,
I F Casson, and J N Harvey, and M R Lee
Enzymatic O-methylation of catechols and catecholamines.
December 1982, Pharmaceutisch weekblad. Scientific edition,
I F Casson, and J N Harvey, and M R Lee
Enzymatic N-O-methylation of hydroxamic acids.
December 1968, Biochimica et biophysica acta,
I F Casson, and J N Harvey, and M R Lee
Desferrioxamine induced aluminium removal in haemodialysis.
January 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress,
Copied contents to your clipboard!